FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

421637006: Lyophilized powder for conventional release solution for injection (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2614904011 Lyophilized powder for injectable solution (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
2617529016 Lyophilised powder for injectable solution en Synonym Inactive Entire term case insensitive SNOMED CT core module
2617530014 Lyophilized powder for injectable solution en Synonym Inactive Entire term case insensitive SNOMED CT core module
2660521017 Lyophilized powder for injectable solution (qualifier value) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3636025015 Lyophilized powder for conventional release solution for injection (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3636026019 Lyophilised powder for conventional release solution for injection en Synonym Active Entire term case insensitive SNOMED CT core module
3636027011 Lyophilized powder for conventional release solution for injection en Synonym Active Entire term case insensitive SNOMED CT core module
3636028018 Lyophilized powder for solution for injection en Synonym Active Entire term case insensitive SNOMED CT core module
3636029014 Lyophilised powder for solution for injection en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lyophilized powder for conventional release solution for injection Is a Powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Lyophilized powder for conventional release solution for injection Has dose form administration method Inject true Inferred relationship Existential restriction modifier
Lyophilized powder for conventional release solution for injection Has dose form transformation Dissolve true Inferred relationship Existential restriction modifier
Lyophilized powder for conventional release solution for injection Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Lyophilized powder for conventional release solution for injection Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Lyophilized powder for conventional release solution for injection Is a Parenteral dose form false Inferred relationship Existential restriction modifier
Lyophilized powder for conventional release solution for injection Has basic dose form Lyophilized powder true Inferred relationship Existential restriction modifier
Lyophilized powder for conventional release solution for injection Is a Lyophilized powder for conventional release solution for infusion and/or injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely Clostridium histolyticum collagenase 900 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Velaglucerase alfa 200unit lyophilized powder for injection solution Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely belimumab 400 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for injection solution Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely human immunoglobulin G 6 gram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely octocog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely octocog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely lurbinectedin 4 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely remimazolam (as remimazolam besylate) 20 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely Clostridium histolyticum collagenase 900 microgram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier
Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start